119 related articles for article (PubMed ID: 3992596)
1. Preparation and characterization of monoclonal antibody specific for Naja nivea cardiotoxin VII1.
Kfir R; Botes DP; Osthoff G
Toxicon; 1985; 23(1):135-44. PubMed ID: 3992596
[TBL] [Abstract][Full Text] [Related]
2. Probing the functional sites in Naja naja atra (Taiwan cobra) cardiotoxin III with monoclonal antibody.
Chang KL; Chen YS; Lin SR; Chang LS; Chang CC
Biochem Mol Biol Int; 1993 Apr; 29(6):1015-22. PubMed ID: 8330009
[TBL] [Abstract][Full Text] [Related]
3. Far-u.v. CD-spectroscopy and immunological properties of synthetic sequential peptides derived from cardiotoxin VII1 of Naja nivea venom: an amphipathic alpha-helix formed by sequence 15-25 of a beta-protein.
Osthoff G
Int J Biochem; 1989; 21(12):1365-8. PubMed ID: 2482207
[TBL] [Abstract][Full Text] [Related]
4. Two neutralizing monoclonal antibodies specific for Naja nigricollis cardiotoxin: preparation, characterization and localization of the epitopes.
Grognet JM; Gatineau E; Bougis P; Harvey AL; Couderc J; Fromageot P; Ménez A
Mol Immunol; 1986 Dec; 23(12):1329-37. PubMed ID: 2434844
[TBL] [Abstract][Full Text] [Related]
5. Effects of cardiotoxin D from Naja naja siamensis snake venom upon murine splenic lymphocytes.
Hinman CL; Lepisto E; Stevens R; Montgomery IN; Rauch HC; Hudson RA
Toxicon; 1987; 25(9):1011-4. PubMed ID: 3433298
[TBL] [Abstract][Full Text] [Related]
6. The oxidation of methionine and its effect of the properties of cardiotoxin VII1 from Naja melanoleuca venom.
Carlsson FH; Louw AI
Biochim Biophys Acta; 1978 Jun; 534(2):322-30. PubMed ID: 96866
[TBL] [Abstract][Full Text] [Related]
7. Six isoforms of cardiotoxin in malayan spitting cobra (Naja naja sputatrix) venom: cloning and characterization of cDNAs.
Jeyaseelan K; Armugam A; Lachumanan R; Tan CH; Tan NH
Biochim Biophys Acta; 1998 Apr; 1380(2):209-22. PubMed ID: 9565688
[TBL] [Abstract][Full Text] [Related]
8. Complete amino acid sequences of two cardiotoxin-like analogues from Bungarus fasciatus (banded krait) snake venom.
Lu HS; Lo TB
Toxicon; 1981; 19(1):103-11. PubMed ID: 6784277
[No Abstract] [Full Text] [Related]
9. Hemolytic activity of thionin from Pyrularia pubera nuts and snake venom toxins of Naja naja species: Pyrularia thionin and snake venom cardiotoxin compete for the same membrane site.
Osorio e Castro VR; Vernon LP
Toxicon; 1989; 27(5):511-7. PubMed ID: 2749751
[TBL] [Abstract][Full Text] [Related]
10. Properties of some 3-nitrotyrosyl elapid venom cardiotoxins.
Carlsson FH; Louw AI
Int J Biochem; 1987; 19(1):9-16. PubMed ID: 3569641
[TBL] [Abstract][Full Text] [Related]
11. Characterization of monoclonal antibodies against Naja naja oxiana neurotoxin I.
Stiles BG; Sexton FW; Guest SB; Olson MA; Hack DC
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):163-70. PubMed ID: 7945236
[TBL] [Abstract][Full Text] [Related]
12. The preparation of 3-nitrotyrosyl derivatives of three elapid venom cardiotoxins.
Carlsson FH
Biochim Biophys Acta; 1980 Aug; 624(2):460-72. PubMed ID: 7417487
[TBL] [Abstract][Full Text] [Related]
13. Affinity chromatography of phospholipase A2 from Naja naja naja (Indian cobra) venom.
Hazlett TL; Dennis EA
Toxicon; 1985; 23(3):457-66. PubMed ID: 3927524
[TBL] [Abstract][Full Text] [Related]
14. Effects of divalent cations on snake venom cardiotoxin-induced hemolysis and 3H-deoxyglucose-6-phosphate release from human red blood cells.
Jiang MS; Fletcher JE; Smith LA
Toxicon; 1989; 27(12):1297-305. PubMed ID: 2629171
[TBL] [Abstract][Full Text] [Related]
15. Separation of cardiotoxins (cytotoxins) from the venoms of Naja naja and Naja naja atra by reversed-phase high-performance liquid chromatography.
Kaneda N; Hayashi K
J Chromatogr; 1983 Dec; 281():389-92. PubMed ID: 6668340
[No Abstract] [Full Text] [Related]
16. Cardiotoxins from the venom of Malayan cobra (Naja naja sputatrix).
Tan NH
Arch Biochem Biophys; 1982 Oct; 218(1):51-8. PubMed ID: 7149742
[No Abstract] [Full Text] [Related]
17. In vivo synergy of cardiotoxin and phospholipase A2 from the elapid snake Naja mossambica mossambica.
Bougis PE; Marchot P; Rochat H
Toxicon; 1987; 25(4):427-31. PubMed ID: 3617080
[TBL] [Abstract][Full Text] [Related]
18. Hybridoma technology.
Price PJ
Ric Clin Lab; 1984; 14(3):277-86. PubMed ID: 6395287
[No Abstract] [Full Text] [Related]
19. Use of erythrocyte hemolysis kinetics in the purification of complex cardiotoxin mixtures.
Zusman N; Cafmeyer N; Hudson RA
Toxicon; 1982; 20(2):517-20. PubMed ID: 7080058
[TBL] [Abstract][Full Text] [Related]
20. Ablation of natural killer cell function by soluble cardiotoxin.
Xiao LJ; Hinman CL
Int J Immunopharmacol; 1990; 12(3):247-54. PubMed ID: 2329017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
